A Aralex Aachen research explorer

May 09, 2019 article

Atezolizumab plus bevacizumab versus sunitinib in patients with previously untreated metastatic renal cell carcinoma (IMmotion151): a multicentre, open-label, phase 3, randomised controlled trial

DOI: 10.1016/s0140-6736(19)30723-8 OpenAlex

Authors 0

Author list not loaded yet.

Cited by 4 stored of 1,032

Immunological features of clear-cell renal-cell carcinoma and resistance to immune checkpoint inhibitors
2025 Nature Reviews Nephrology review Medicine Cancer Immunotherapy and Biomarkers

40

citations
High serum sodium predicts immunotherapy response in metastatic renal cell and urothelial carcinoma
2024 European Journal of Cancer article Medicine Cancer Immunotherapy and Biomarkers Open access

13

citations
Systemic Therapy of Common Tumours in Older Patients: Challenges and Opportunities. A Young International Society of Geriatric Oncology Review Paper
2020 Current Oncology Reports article Medicine Frailty in Older Adults

7

citations
Multicentric Analytical and Inter-observer Comparability of Four Clinically Developed Programmed Death-ligand 1 Immunohistochemistry Assays in Advanced Clear-cell Renal Cell Carcinoma
2020 Clinical Genitourinary Cancer article Medicine Cancer Immunotherapy and Biomarkers Open access

13

citations

4 results

References 0